Literature DB >> 31375284

Human cerebral malaria: 2019 mini review.

F Bruneel1.   

Abstract

During severe malaria, both in endemic and non-endemic areas, cerebral malaria is strongly associated with mortality and morbidity. The main mechanisms of cerebral malaria combine sequestration of parasitized red blood cells in brain capillaries, production of cytokines, immune cell/platelet accumulation, and release of microparticules, finally resulting in endothelial lesions of the blood brain barrier, which contribute to various brain injuries (oedema, ischemia, haemorrhages). The neurological clinical findings range from simple delirium to profound coma. Fundoscopy, reflect of the brain microcirculation, is now currently realized in endemic areas, and should be recommended during imported cerebral malaria. Likewise, cerebral imaging should be systematically realized in patients with cerebral malaria. Intravenous artesunate is now firmly established as the treatment of choice for severe malaria worldwide in adults, children and during pregnancy. General care and supportive treatment are crucially important and supportive treatment of cerebral malaria should be better standardized. Finally, experimental and clinical research has a key role in cerebral malaria, so as to identify possible therapeutic targets in order to develop innovative therapies.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Artesunate; Cerebral Malaria; Mortality; Neuroimaging; Sequestration

Mesh:

Year:  2019        PMID: 31375284     DOI: 10.1016/j.neurol.2019.07.008

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  9 in total

1.  Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation.

Authors:  Jacob Golenser; Nadeen Salaymeh; Abd Alroof Higazi; Mohammed Alyan; Mahran Daif; Ron Dzikowski; Abraham J Domb
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810

2.  Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations.

Authors:  Omkar Indari; Budhadev Baral; Kartik Muduli; Ambika Prasad Mohanty; Natabar Swain; Nirmal Kumar Mohakud; Hem Chandra Jha
Journal:  Biosaf Health       Date:  2021-04-30

Review 3.  Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.

Authors:  I A Clark; B Vissel
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 4.  Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic.

Authors:  Ian Albert Clark
Journal:  Pharmacol Res Perspect       Date:  2022-04

Review 5.  Malaria Related Neurocognitive Deficits and Behavioral Alterations.

Authors:  Pamela Rosa-Gonçalves; Flávia Lima Ribeiro-Gomes; Cláudio Tadeu Daniel-Ribeiro
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293

6.  Increased Expression of Multiple Co-Inhibitory Molecules on Malaria-Induced CD8+ T Cells Are Associated With Increased Function Instead of Exhaustion.

Authors:  Johannes Brandi; Mathias Riehn; Alexandros Hadjilaou; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 7.  Neurotransmitters and molecular chaperones interactions in cerebral malaria: Is there a missing link?

Authors:  Michael Oluwatoyin Daniyan; Funmilola Adesodun Fisusi; Olufunso Bayo Adeoye
Journal:  Front Mol Biosci       Date:  2022-08-24

8.  Cerebral Malaria Presenting With Shock in an Adolescent: A Case Report.

Authors:  Deborah Omoleye; Muhammad A Israr; Faria Tazin; Camille Celeste Go; Olanrewaju Saheed
Journal:  Cureus       Date:  2022-09-11

9.  Effect of Artesunate on Leishmania Amazonesis Induced Neuroinflammation and Nociceptive Behavior in Male Balb/C Mice.

Authors:  Enrico Gugliandolo; Ernesto Palma; Alessio Filippo Peritore; Rosalba Siracusa; Ramona D'Amico; Roberta Fusco; Patrizia Licata; Rosalia Crupi
Journal:  Animals (Basel)       Date:  2020-03-27       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.